Jr. Lieberman et al., TREATMENT OF THE INFECTED TOTAL HIP-ARTHROPLASTY WITH A 2-STAGE REIMPLANTATION PROTOCOL, Clinical orthopaedics and related research, (301), 1994, pp. 205-212
Forty-four patients (46 hips) with infected total hip arthroplasties w
ere evaluated. They were entered into a protocol that included resecti
on arthroplasty, six weeks of intravenous antibiotics which obtained a
minimum postpeak serum bactericidal titer of 1:8, and possible reimpl
antation. Thirty-two of 46 hips (70%) were reimplanted. At an average
of 40 months (range, 24-74 months) after reimplantation, infection rec
urred in three hips (9%). In two of the three recurrent infections, 1:
8 bactericidal titers were not attained. Both of these hips were infec
ted with gram-negative organisms. Minimum postpeak serum bactericidal
titers of 1:8 were attained in 28 of 32 hips that were reimplanted, an
d only one of these hips (4%) had a recurrent infection (p = 0.035). T
he presence of retained cement after resection arthroplasty (ten hips)
was not associated with recurrent infection. Fourteen hips (12 patien
ts) were not reimplanted as a result of a combination of factors, incl
uding inadequate bone stock, poor soft-tissue quality, and antibiotic
resistance of the infecting organism. The treatment of an infected tot
al hip arthroplasty with resection arthroplasty, six weeks of intraven
ous antibiotics that attains a minimum postpeak serum bactericidal tit
er of 1:8, and reimplantation can be an effective and safe treatment.